海纳医药递表港交所
Zhi Tong Cai Jing·2025-11-09 08:49
Group 1 - Nanjing Healthnice Pharmaceutical Technology Co., Ltd. has submitted its listing application to the Hong Kong Stock Exchange, with CICC acting as the sole sponsor [1] - The company integrates pharmaceutical research and manufacturing, providing CXO services and has proprietary product pipelines that are commercialized mainly through technology transfer [1] - According to Frost & Sullivan, Healthnice ranks second among CXO service providers in China in terms of the number of clinical trial and market approval applications submitted during the reporting period [1]